We monitored renal tubular function in 18 neuroblastoma patients treated with chemotherapeutic regimens containing Ifosfamide and platinates. The total IFO dose ranged from 30 to 48 g/m2. After each IFO course and at regular intervals during follow-up 24 hour urinary exception of aminoacids, qualitative excretion of protein and glucose, tubular reabsorption of phosphate, serum pH, and liver enzyme (SGOT and SGPT) were measured. The ratio of alpha-amino-Nitrogen/total-Nitrogen (normal less than 2.5%) and the urinary excretion pattern were used to quantify the aminoaciduria in 12 out of 15 evaluable patients some degree of tubular toxicity occurred during treatment, slowly progressing to a Debré-de Toni-Fanconi syndrome (DTFS) in 7 patients. The DTFS was fully developed in most cases 3-9 months after the end of treatment and was reversible in 3 cases. Hyperaminoaciduria (HAA) occurred in all patients during treatment, preceding other signs of tubular toxicity. The maximum ratio measured before development of a DTFS was significantly higher in the patients with severe toxicity (P less than .01). HAA characterized by a ratio greater than 10% predicts the development of a DTFS with a sensitivity of 71.4% and a specificity of 87.4%.
Background: Sialic acid storage diseases (SSDs) are severe autosomal recessive neurodegenerative disorders caused by a transport defect across the lysosomal membrane, which leads to accumulation of sialic acid in tissues, fibroblasts, and urine. Defective free sialic acid transport can be established by quantification of free sialic acid in urine. Methods: Urine sample size was adjusted to the equivalent of 100 nmol of creatinine. After addition of 2-keto-3-deoxy-D-glycero-D-galactonononic acid as internal standard, samples were diluted with water to an end volume of 250 L. We used 10 L for HPLC-tandem mass spectrometric analysis in the negative electrospray ionization mode, monitoring transitions m/z 308.33m/z 86.9 (sialic acid) and m/z 267.23m/z 86.9 (internal standard). The overall method was validated and studied for ion suppression, interfering compounds, and pH effects. Samples from controls (n ؍ 72) and SSD patients (n ؍ 3) were analyzed. Results: The limit of detection was 3 mol/L. Intraassay imprecision (CV; n ؍ 10) was 6%, 3%, and 2% at 30, 130, and 1000 mmol/mol creatinine, respectively; corresponding interassay CV (n ؍ 10) were 5%, 5%, and 2%. Recovery was 109% (100 -1000 mmol/mol creatinine). (2, 4 -6 ).The known forms of SSD are primarily caused by a transport defect across the lysosomal membrane (3, 7 ), which leads to the accumulation of free sialic acid [Nacetylneuraminic acid (NANA); Fig. 1] in tissues, fibroblasts, and urine. The origin of the transport defect lies in a mutation in the SLC17A5 gene, which encodes for sialin protein (8, 9 ).Defective free sialic acid transport can be established by quantitative analysis of NANA in urine relative to the concentration of creatinine. Several types of analysis are available to quantify NANA, including colorimetric methods (10, 11 ), thin-layer chromatography (12 ), gas chromatography-mass spectrometry (12, 13 ), HPLC with fluorescence detection (14 ), HPLC with ultraviolet detection (15 ), enzymatic assays (14, 16 ), high-performance anionexchange chromatography with pulsed amperometric detection (HPAE-PAD) (17,18 ), and HPLC with mass spectrometry (HPLC-MS) (19,20 ). The main disadvantages of these methods are a lack of selectivity, a lack of speed, or both. For example, enzymatic methods appear to be more accurate than colorimetric methods (16,21 ), but neither method can differentiate among different neuraminic acids; HPAE-PAD, used mainly for the analysis of sialic acids released from glycoconjugates, can reduce the possibility of interferences by relatively long gradient separations. 20 ) are more selective and sensitive, but they are still time-consuming, multistep methods that have not been validated as a rapid diagnostic tool.In this report we describe and validate a simple, rapid, selective, and sensitive method for the analysis of NANA in urine samples based on HPLC combined with tandem MS (HPLC-tMS). The deaminated sialic acid 2-keto-3-deoxy-d-glycero-d-galactonononic acid (KDN) was used as an internal standard (IS) (17, 22 ) (s...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.